Sepp-Lorenzino Laura - Insider Non-Derivative Transactions at Intellia Therapeutics, Inc. (NTLA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 1, 2024, Sepp-Lorenzino Laura's relationship to Intellia Therapeutics, Inc. (NTLA) is Officer (EVP, Chief Scientific Officer), and currently has 81,893 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NTLA insiders.
Data Source: SEC.
Sepp-Lorenzino Laura - Insider Non-Derivative Transactions of NTLA Common Stock
Sepp-Lorenzino Laura - Insider Non-Derivative Transactions at NTLA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 2, 2024 | Acquisition -- (Common Stock) | 37966 | 0 | 81893 |
| Jan 9, 2024 | Sell -- (Common Stock) | 667 | 29.38 | 43927 |
| Jan 9, 2024 | Sell -- (Common Stock) | 1608 | 28.66 | 44594 |
| Jan 4, 2024 | Sell -- (Common Stock) | 5532 | 29.46 | 46202 |
| Jan 2, 2024 | M -- (Common Stock) | 3500 | 0 | 51734 |
| Mar 2, 2023 | Acquisition -- (Common Stock) | 29938 | 0 | 47567 |
| Jan 6, 2023 | Sell -- (Common Stock) | 689 | 39.1 | 17629 |
| Jan 6, 2023 | Sell -- (Common Stock) | 1641 | 38.22 | 18318 |
| Jan 5, 2023 | Sell -- (Common Stock) | 2508 | 37.21 | 19959 |
| Jan 2, 2023 | M -- (Common Stock) | 3500 | 0 | 22467 |